Skip to main content
OpenTrials

Clinical trial condition

Primary hyperoxaluria type 1

Explore clinical trials studying Primary hyperoxaluria type 1. Study availability and eligibility vary by location and protocol.

20 public trials 7 recruiting studies
Refine in advanced search Browse all conditions

Primary hyperoxaluria type 1 trial results

Active, not recruiting

Long Term Extension Study in Patients With Primary Hyperoxaluria

NCT04042402

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, +17 more
Locations
  • Clinical Research Site San Francisco, California, United States
  • Clinical Trial Site Boston, Massachusetts, United States
  • Clinical Trial Site Rochester, Minnesota, United States
  • Clinical Trial Site New York, United States
View all 23 locations
View Trial Details
Completed

Nedosiran in Pediatric Patients From Birth to 11 Years of Age With PH and Relatively Intact Renal Function

NCT05001269

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, +17 more
Locations
  • Clinical Research Site Rochester, Minnesota, United States
  • Clinical Research Site Hamilton, Ontario, Canada
  • Clinical Trial Site Bonn, Germany
  • Clinical Research Site Heidelberg, Germany
View all 13 locations
View Trial Details
Completed

A Study to Evaluate Lumasiran in Patients With Advanced Primary Hyperoxaluria Type 1

NCT04152200

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, +14 more
Locations
  • Clinical Trial Site Rochester, Minnesota, United States
  • Clinical Trial Site Houston, Texas, United States
  • Clinical Trial Site Garran, Australia
  • Clinical Trial Site Brussels, Belgium
View all 14 locations
View Trial Details
Completed

A Study of Lumasiran in Infants and Young Children With Primary Hyperoxaluria Type 1

NCT03905694

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, +14 more
Locations
  • Clinical Trial Site Rochester, Minnesota, United States
  • Clinical Trial Site Houston, Texas, United States
  • Clinical Trial Site Lyon, France
  • Clinical Trial Site Paris, France
View Trial Details
Completed

A Study to Evaluate Lumasiran in Children and Adults With Primary Hyperoxaluria Type 1

NCT03681184

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, +13 more
Locations
  • Clinical Trial Site San Diego, California, United States
  • Clinical Trial Site Jacksonville, Florida, United States
  • Clinical Trial Site Rochester, Minnesota, United States
  • Clinical Trial Site New York, United States
View all 17 locations
View Trial Details
Completed

A Study to Evaluate DCR-PHXC in Children and Adults With Primary Hyperoxaluria Type 1 and Primary Hyperoxaluria Type 2

NCT03847909

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, +16 more
Locations
  • Clinical Trial Site San Francisco, California, United States
  • Clinical Trial Site Boston, Massachusetts, United States
  • Clinical Trial Site Rochester, Minnesota, United States
  • Clinical Trial Site New York, United States
View all 28 locations
View Trial Details
Completed

Study of Lumasiran in Healthy Adults and Patients With Primary Hyperoxaluria Type 1

NCT02706886

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, +13 more
Locations
  • Clinical Trial Site Bordeaux, France
  • Clinical Trial Site Lyon, France
  • Clinical Trial Site Paris, France
  • Clinical Trial Site Bonn, Germany
View Trial Details

Related conditions